Authors

Rupesh Kotecha, Miami Cancer InstituteFollow
Eyub Akdemir, Miami Cancer InstituteFollow
Tugce Kutuk, Miami Cancer InstituteFollow
Manmeet Ahluwalia, Miami Cancer InstituteFollow
Michael McDermott, Miami Neuroscience InstituteFollow
Yazmin Odia, Miami Cancer InstituteFollow
Minesh Mehta, Miami Cancer InstituteFollow

Benchmarking the efficacy of salvage systemic therapies for recurrent meningioma: A RANO group systematic review and meta-analysis to guide clinical trial design

Publication Date

9-8-2025

Content Type

Article

PubMed ID:

39807850

Additional Authors:

Additional authors and institutional affiliations

Citation

Kotecha, R., Akdemir, E. Y., Kutuk, T., Ilgın, C., Ahluwalia, M. S., Bi, W. L., Blakeley, J., Dixit, K. S., Dunn, I. F., Galanis, E., Galldiks, N., Huang, R. Y., Johnson, D. R., Kaley, T. J., Kamson, D. O., Kurz, S. C., McDermott, M. W., Odia, Y., Preusser, M., Raizer, J., … Mehta, M. P. (2025). Benchmarking the efficacy of salvage systemic therapies for recurrent meningioma: A RANO group systematic review and meta-analysis to guide clinical trial design. Neuro-oncology, 27(7), 1670–1685. https://doi.org/10.1093/neuonc/noaf009